Healthcare Industry Sevoflurane, Isoflurane and Desflurane Market | Seite 2

Your Catalyst To a Lucrative Business
Products Overview
Sevoflurane
Sevoflurane is one of the most commonly used volatile anesthetic agents. It is administered to babies and
children. Sevoflurane is ideal for patients with asthma or sensitive air passages. But its side -effects include
delirium and agitation. It can be given quickly without the use of intravenous instruments.
Sevoflurane would capture over 70% of the worldwide sevoflurane, isoflurane and desflurane market by
2022. The agent is expected to exceed USD 1 billion by the same year. It’s w idely utilized for being low-priced
and possessing therapeutic benefits.
Isoflurane
Isoflurane is a halogen ether utilized frequently by veterinarians. It is administered intravenously, relaxes the
muscles and reduces pain. Isoflurane has also been used for inducing sleepiness for long durations during
surgery. It is expected to register a CAGR of about 10% by 2022.
Desflurane
Desflurane is a halogen ether used in general anesthesia. Its effectiveness is one-fifth of isoflurane.
Desflurane cannot be administered orally and requires an electrically heated dispenser to distribute the
vapor. It is mostly administered to bariatric patients and in cases of surgeries lasting for short durations.
Regional Overview
The United States has a large geriatric population. This has led the region of North America to occupy the
biggest share in the worldwide inhalation anesthesia market in 2014. Surgical ambulatory and inpatient
procedures are the driving factors of North America.
Asia Pacific will experience the fastest growth by 2022. This is owing to the rise of chronic diseases and need
for better health infrastructure in the region. Medical tourism combined with insurance coverage will play a
huge role in sustaining the growth of the sevoflurane, isoflurane and desflurane market.
Key Players
The market is currently dominated by AbbVie and Baxter International. However, it can expect strong
competition from manufacturers like Lunan Pharmaceutical Group and Piramal Enterprises.
Piramal Enterprises currently has isoflurane and sevoflurane production underway. It will manufacture
generic desflurane by 2016. AbbVie has sevoflurane and isoflurane under production. Baxter International is
the only one that manufactures all the three products.
Anesthesia has some unhealthy effects. The recycling companies of Deltasorb Technologies and Anesthetic
Gas Rec